Societal impacts of regenerative medicine: Reflections on the views of orthopedic professionals

Regenerative Medicine

Volumn 10, Issue 1, 2015, Pages 17-24

  Niemansburg, Sophie L ^a   Tempels, Tjidde H ^a,b   Dhert, Wouter Ja ^a   Van Delden, Johannes Jm ^a   Bredenoord, Annelien L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

empirical research; ethics; regenerative medicine; societal impacts; stem cells; translational medical research

Indexed keywords

AGING; ARTICLE; EMPIRICAL RESEARCH; FEMALE; HUMAN; MALE; ORTHOPEDIC SPECIALIST; PHYSICIAN ATTITUDE; PROPHYLAXIS; QUALITATIVE RESEARCH; REGENERATIVE MEDICINE; SOCIAL ASPECT; SOCIAL JUSTICE; DISEASES; HEALTH CARE PERSONNEL; ORTHOPEDICS; PHYSIOLOGY; SOCIAL CHANGE; TRENDS;

AGING; DISEASE; HEALTH PERSONNEL; HUMANS; ORTHOPEDICS; REGENERATIVE MEDICINE; SOCIAL CHANGE; SOCIAL JUSTICE;

EID: 84920747835     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.14.69     Document Type: Article

References (35)

1. Bijker WE. Why and how technology matters. In:Oxford Handbook of Contextual Political Analysis. Goodin RE, Tilly C (Eds). Oxford University Press, Oxford, UK (2006).
2. Li MD, Atkins H, Bubela T. The global landscape of stem cell clinical trials. Regen. Med. 9(1), 27-39 (2014).
3. Martin I, Baldomero H, Bocelli-Tyndall C, Passweg J, Saris D, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2010. Tissue Eng. Part A 18(21-22), 2268-2279 (2012).
4. Paesold G, Nerlich AG, Boos N. Biological treatment strategies for disc degeneration: potentials and shortcomings. Eur. Spine J. 16(4), 447-468 (2007).
5. Daar AS, Greenwood HL. A proposed definition of regenerative medicine. J. Tissue Eng. Regen. Med. 1(3), 179-184 (2007).
6. Niemansburg SL, van Delden JJ, Dhert WJ, Bredenoord AL. Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients. Regen. Med. 8(1), 65-73 (2013).
7. Niemansburg SL, Teraa M, Hesam H, van Delden JJ, Verhaar MC, Bredenoord AL. Stem cell trials for vascular medicine: ethical rationale. Tissue Eng. Part A 20(19-20), 2567-2574 (2013).
8. Lo B, Parham L. Ethical issues in stem cell research. Endocr. Rev. 30(3), 204-213 (2009).
9. Woolf SH. The meaning of translational research and why it matters. JAMA 299(2), 211-213 (2008).
10. Oerlemans AJ, van Hoek ME, van Leeuwen E, van der Burg S, Dekkers WJ. Towards a richer debate on tissue engineering: a consideration on the basis of NEST-ethics. Sci. Eng. Ethics 19(3), 963-981 (2013).
11. Hussain A, Rivers PA. The economic value of investing in regenerative medicine. J. Health Care Finance 36(2), 45-54 (2009).
12. van der Burg S. Taking the soft impacts of technology into account: broadening the discourse in research practice. Soc. Epistemol. 23(3-4), 301-316 (2009).
13. Trommelmans L. The challenge of regenerative medicine. Hastings Cent. Rep. 40(6), 24-26 (2010).
14. Horstman K. From laboratory to practice: learning about normative issues. In:Converging Technologies: Innovation Patterns and Impacts on Society. van Doorn M (Ed.). Netherlands Study Centre for Technology Trends, The Hague, The Netherlands (2006).
15. Verbeek P-P. Technology design as experimental ethics. In:Ethics on the Laboratory Floor. van der Burg S, Swierstra T (Eds). Palgrave Macmillan, NY, USA (2013).
16. Polit DF, Beck CT. Nursing Research: Principles and Methods. Lippincott Williams &Wilkins, PA, USA (2003).
17. Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. BMJ 337, a288 (2008).
18. Creswell JW. Qualitative Inquiry and Research Design: Choosing among Five Traditions (3rd Edition). SAGE Publications, CA, USA (1998).
19. Niemansburg SL, van Delden JJ, Oner FC, Dhert WJ, Bredenoord AL. Ethical implications of regenerative medicine in orthopedics: an empirical study with surgeons and scientists in the field. Spine J. 14(6), 1029-1035 (2013).
20. Guest G, Brunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods 18, 59-82 (2006).
21. Corbin J, Strauss AL. Basics of qualitative research. Techniques and Procedures for Developing Grounded Theory. SAGE Publications, CA, USA (2008).
22. Negotiation in Academic Medicine: narratives of faculty researchers and their mentors NVivo 8.(8.0.332.0.SP4) (2012).
23. Juengst ET. What does enhancement mean? In:Enhancing Human Traits: Ethical and Social Implications. Parens E (Ed.). Georgetown University Press, Washington DC, USA (1998).
24. Schweda M, Marckmann G. How do we want to grow old? Anti-ageing-medicine and the scope of public healthcare in liberal democracies. Bioethics 27(7), 357-364 (2013).
25. Schermer M. Old age is an incurable disease -or is it? In: Ethics, Health Policy and (Anti-)Aging: Mixed Blessings. Springer, NY, USA (2008).
26. Masuda K. Biological repair of the degenerated intervertebral disc by the injection of growth factors. Eur. Spine J. 17(Suppl. 4), 441-451 (2008).
27. Ganey T, Hutton WC, Moseley T, Hedrick M, Meisel HJ. Intervertebral disc repair using adipose tissue-derived stem and regenerative cells: experiments in a canine model. Spine (Phila Pa 1976) 34(21), 2297-2304 (2009).
28. Verweij M. Medicalization as a moral problem for preventative medicine. Bioethics 13(2), 89-113 (1999).
29. Martin D. Professional and public ethics united in condemnation of transplant tourism. Am. J. Bioeth. 10(2), 18-20 (2010).
30. Nowotny H, Scott P, Gibbons M. Re-thinking Science. Knowledge and the Public in An Age of Uncertainty. Nowotny H (Ed.). Wiley-Blackwell, NJ, USA (2001).
31. van der Burg S, Swierstra T. Enhancing ethical reflection in the laboratory: how soft impacts require tough thinking. In:Ethics on the Laboratory Floor. van der Burg S, Swierstra T (Eds). Palgrave Macmillan, NY, USA (2013).
32. Derksen MH, Horstman K. Engineering flesh: towards an ethics of lived integrity. Med. Health Care Philos. 11(3), 269-283 (2008).
33. Latour B. Science in Action: How to Follow Scientists and Engineers Through Society. Harvard University Press, MA, USA (1987).
34. Lafontaine C. Regenerative medicines immortal body: from the fight against ageing to the extension of longevity. Body Soc. 15(4), 53-71 (2009).
35. Lee CL, Scheufele DA, Lewenstein BV. Public attitudes toward emerging technologies. Sci. Commun. 27(2), 240-267 (2005).